Skip to Content

Q50 (Quetiapine Fumarate Extended-Release 50 mg)

Pill with imprint Q50 is Maroon, Elliptical / Oval and has been identified as Quetiapine Fumarate Extended-Release 50 mg. It is supplied by Mallinckrodt Inc..

Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; schizophrenia; depression; major depressive disorder and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Q50

Quetiapine Fumarate Extended-Release

50 mg
8.00 mm
Elliptical / Oval
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mallinckrodt Inc.
National Drug Code (NDC)
Inactive Ingredients
lactose anhydrous, ethylcellulose (100 mPa.s), microcrystalline cellulose, hydroxyethyl cellulose (4000 mpa.s at 1%), magnesium stearate, magnesium silicate, titanium dioxide, ferric oxide yellow, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.